Edgewise Therapeutics reshuffles executive team
BOULDER, Colo. - Edgewise Therapeutics Inc. (NASDAQ:EWTX), a biopharmaceutical company focused on muscle disease treatment ...
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced key changes ...
BizWest3d
Edgewise elevates chief operating officer, hires development exec
Edgewise Therapeutics Inc. (Nasdaq: EWTX) has promoted Behrad Derakhshan, formerly the Boulder-based muscle disease biopharmaceutical company’s chief business officer, to chief operating officer, and ...
Edgewise Therapeutics promotes Behrad Derakhshan to COO
Edgewise Therapeutics (EWTX) announced changes to its executive team. These changes include the addition of Robert Blaustein, joining the ...
Nasdaq5d
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
- Behrad Derakhshan, Ph.D. promoted to Chief Operating Officer (COO) - Robert Blaustein, M.D., Ph.D., Chief Development Officer, Edgewise Therapeutics (Photo ...
Business Wire5d
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
- Robert Blaustein, M.D., Ph.D. appointed as Chief Development Officer (CDO) - BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading ...
Stockhouse5d
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
These changes include the addition of Robert Blaustein, M.D., Ph.D., joining the Company as Chief Development Officer and the promotion of Behrad Derakhshan, Ph.D. from Chief Business Officer to Chief ...